Home › NDC Lookup › J-codes › J8515
J8515

J8515 – Cabergoline, oral, 0.25 mg · NDC Crosswalk & Billing Units

HCPCS Level II J-code · Medicare Part B drug billing
J-code ● 7 NDCs crosswalked per 0.25 MG $0.302/unit ASP+6%

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

📋 J8515 summary

J8515 is a HCPCS Level II J-code used to bill Cabergoline, oral, 0.25 mg, billed per 0.25 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Code J8515 Billing unit 0.25 MG Payment limit $0.302/unit NDC-Crosswalk 7 Quarter Q3 2026 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ8515
DescriptorCabergoline, oral, 0.25 mg
Billing unit0.25 MG
Payment limit / unit$0.302
Est. ASP / unit$0.285 est.
Mapped NDCs7
Data periodQ3 2026
Last updated2026-09-20

💊 About Cabergoline DRUG GUIDE

Cabergoline tablets are used in adults to treat hyperprolactinemic disorders — conditions where the body produces too much prolactin, a hormone made by the pituitary gland.

This excess prolactin can cause irregular periods, unwanted breast milk production, and fertility problems.The cause may be idiopathic (no clear reason found) or due to a pituitary adenoma (a noncancerous tumor on the pituitary gland).

Cabergoline is not approved to stop breast milk production after childbirth, and should not be used for that purpose.

Read the full Cabergoline drug guide →
Clinical overview from our editorial drug guide for Cabergoline. For billing reference, see the sections above.

🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026

📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.302
Est. ASP / unit
$0.285 est.
Est. after 2% sequester
$0.296
HCPCS dosage
0.25 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionCabergoline, oral, 0.25 mg
CoverageM — Non-covered by Medicare
Pricing indicator00 — Not separately priced (bundled)
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date2006-01-01
Date added2006-01-01
Source: CMS HCPCS Level II code file (imported via admin).

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J8515 = 0.25 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J8515 LEAST EXPENSIVE FIRST

7 NDCs map to J8515. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.302/unit) × that package's bill units.
NDC (11-digit)DrugLabelerPackageStrength Bill units Est. pay / pkg NADAC / unit StatusSource
69238-2693-01 Cabergoline .5 mg/1 TABLET Amneal 8 TABLET in 1 BOTTLE (69238-2693-1) .5 mg/1 16 $4.83 $1.295 ● Active CMS + PDAC
70069-0824-08 CABERGOLINE .5 mg/1 TABLET Somerset 8 TABLET in 1 BOTTLE (70069-824-08) .5 mg/1 2 $0.60 $1.295 ● Active PDAC
70512-0860-08 Cabergoline .5 mg/1 TABLET SOLA 8 TABLET in 1 BOTTLE (70512-860-08) .5 mg/1 2 $0.60 $1.295 ● Active PDAC
23155-0823-73 Cabergoline .5 mg/1 TABLET Heritage 8 TABLET in 1 BOTTLE (23155-823-73) .5 mg/1 2 $0.60 $1.295 ● Active PDAC
50742-0118-08 Cabergoline .5 mg/1 TABLET Ingenus 8 TABLET in 1 BOTTLE (50742-118-08) .5 mg/1 2 $0.60 $1.295 ● Active PDAC
00093-5420-88 Cabergoline .5 mg/1 TABLET Teva 1 BOTTLE in 1 CARTON (0093-5420-88) / 8 T... .5 mg/1 2 $0.60 $1.295 ● Active PDAC
49884-0673-14 CABERGOLINE 0.5 MG Unknown — — 2 $0.60 — — PDAC
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

📈 Medicare Part B claims detail CMS PSPS · 2024

Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
—
Medicare paid
$0.00
Submitted services
—
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.

🗺️ Where J8515 is utilized

⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.

📊 What bills under J8515

J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.

NDC products by ingredient
Cabergoline 4
CABERGOLINE 1
cabergoline 1
NDC products by labeler
Teva Pharmaceuticals USA, Inc. 1
Heritage Pharmaceuticals Inc. d/b/... 1
Ingenus Pharmaceuticals, LLC 1
Amneal Pharmaceuticals NY LLC 1
Somerset Therapeutics, LLC 1
SOLA Pharmaceuticals, LLC 1

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-09-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
7 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
No reportable utilization
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

  • A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
  • Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
  • Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
  • Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
  • The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
  • Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J8515 billing FAQ

What is HCPCS code J8515?
J8515 is a HCPCS Level II J-code used to bill Cabergoline, oral, 0.25 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J8515?
One unit of J8515 represents 0.25 MG. Report the number of units equal to the dose administered divided by 0.25 MG.
How many units of J8515 should I bill?
Divide the dose administered by the code's unit size (0.25 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J8515?
The Medicare Part B payment limit is $0.302 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.296 per unit. Payment limits are revised quarterly.
Which NDCs bill under J8515?
7 NDCs currently map to J8515 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J8515 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.